| Income Statement |
| Total Revenue | 1.85B |
|
| Revenues (USD) | 2.12B |
| Cost of Revenue | 890.14M |
| Gross Profit | 957.93M |
| Operating Expenses | 413.14M |
| Research and Development Expense | 245.18M |
| Selling, General and Administrative Expense | 160.58M |
| Operating Income | 544.79M |
| Interest Expense | 11.21M |
| Income Tax Expense | 123.47M |
| Net Income | 412.86M |
| Net Income Common Stock | 412.86M |
| Net Income Common Stock (USD) | 474.56M |
| Consolidated Income | 413.36M |
| Net Income to Non-Controlling Interests | 498.00K |
| Earnings per Basic Share | 2.33 |
| Earnings per Basic Share (USD) | 2.68 |
| Earnings per Diluted Share | 2.33 |
| Earning Before Interest & Taxes (EBIT) | 547.55M |
| Earning Before Interest & Taxes (USD) | 629.37M |
| Weighted Average Shares | 177.28M |
| Balance Sheet |
| Cash and Equivalents | 1.86B |
| Cash and Equivalents (USD) | 2.13B |
| Investments | 1.84B |
| Investments Current | 1.74B |
| Investments Non-Current | 98.92M |
| Trade and Non-Trade Receivables | 378.91M |
| Current Assets | 5.35B |
| Property, Plant & Equipment Net | 2.12B |
| Total Assets | 10.24B |
| Total Debt | 2.97B |
| Total Liabilities | 6.18B |
| Shareholders Equity | 4.05B |
| Shareholders Equity (USD) | 4.65B |
| Assets Non-Current | 4.89B |
| Total Debt (USD) | 3.41B |
| Goodwill and Intangible Assets | 2.44B |
| Inventory | 1.15B |
| Trade and Non-Trade Payables | 943.35M |
| Tax Assets | 240.90M |
| Tax Liabilities | 334.77M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 173.74M |
| Net Cash Flow from Financing | -222.85M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 389.66M |
| Capital Expenditure | -134.52M |
| Issuance (Purchase) of Equity Shares | -225.80M |
| Issuance (Repayment) of Debt Securities | 2.95M |
| Net Cash Flow from Investing | -252.85M |
| Net Cash Flow from Operations | 863.38M |
| Effect of Exchange Rate Changes on Cash | 1.99M |